TB500 is a synthetic version of an active region of thymosin β4. TB500 is claimed to promote endothelial cell differentiation, angiogenesis in dermal tissues, keratinocyte migration, collagen deposition and decrease inflammation.
CAT No: R1711
CAS No: 885340-08-9
Synonyms/Alias: TB500;885340-08-9;UNII-QHK6Z47GTG;QHK6Z47GTG;TB-500;(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid;TB 500;L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-alpha-glutamyl-L-threonyl-;(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-6-aminohexanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxybutanoyl]amino]-5-amino-5-oxopentanoic acid; TB 500;HY-P0170;TB 500 acetate;GLXC-26514;EX-A7411;TB500?;Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH;AKOS040763972;CS-6213;DA-58320;FT183581;MS-31657;G16402;(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-acetamido-4-methylpentanamido]hexanamido]hexanamido]-3-hydroxybutanamido]-4-carboxybutanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C38H68N10O14 |
M.W/Mr. | 889 |
Sequence | One Letter Code:LKKTETQ Three Letter Code:Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln-OH |
Purity | >98% |
Long-term Storage Conditions | H2O : 50 mg/mL (56.24 mM; Need ultrasonic) |
Shipping Condition | Evaluation sample solution: ship with blue ice. All other available sizes: ship with RT, or blue ice upon request. |
InChI | InChI=1S/C38H68N10O14/c1-19(2)18-27(42-22(5)51)35(58)44-23(10-6-8-16-39)32(55)43-24(11-7-9-17-40)33(56)47-30(20(3)49)36(59)45-25(13-15-29(53)54)34(57)48-31(21(4)50)37(60)46-26(38(61)62)12-14-28(41)52/h19-21,23-27,30-31,49-50H,6-18,39-40H2,1-5H3,(H2,41,52)(H,42,51)(H,43,55)(H,44,58)(H,45,59)(H,46,60)(H,47,56)(H,48,57)(H,53,54)(H,61,62)/t20-,21-,23+,24+,25+,26+,27+,30+,31+/m1/s1 |
InChI Key | ADKDNDYYIZUVCZ-ZQNQAVPYSA-N |
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. The spatiotemporal control of signalling and trafficking of the GLP-1R
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.